Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical

Rui Sun1, Mercedes Bustamante2, Venkatesh Kumar Gurusamy3

  • 1Novartis Pharmaceuticals Corporation, Bannockburn, IL, USA.

PubMed
Abstract